MedTrace Logo

Whole Soy and Daidzein on Reduction of Blood Pressure in Postmenopausal Chinese Women

NCT01270737 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2011-01-05

No results posted yet for this study

Summary

The investigators hypothesize that whole soy or purified daidzein alone could reduce blood pressure and CVD risks in equol-producing menopausal Chinese women.

Conditions

Interventions

DIETARY_SUPPLEMENT

Whole soy (soy flour)

40g soy flour per day for six months

DIETARY_SUPPLEMENT

daidzein

66mg daidzein per day for six months

DIETARY_SUPPLEMENT

milk powder

40g low-fat dry milk per day for six months

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Suzanne C Ho, Professor · Chinese University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
48 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-06-30
Completion
2012-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01270737 on ClinicalTrials.gov